Brochure Available for the World Vaccine Congress

1 Event, 7 Conferences at the World Vaccine Congress 2015 The World Vaccine Congress is back for it’s 15th year on April 7-9 in Washington. With over 250 people already signed up to attend, ranging from pharma and biotech, to non-profits and governmental departments, it is set to be another great year. The event has grown for 2015. Not only …

Sanofi Pasteur Introduces 4-Strain Influenza Vaccine (Fluzone) in Canada

New standard of care for the prevention of influenza A 4-strain influenza vaccine for individuals six months of age and older Helps protect children and adults against an additional influenza B strain October 1, 2014 Sanofi Pasteur, the vaccines division of Sanofi, is pleased to announce the launch of its 4-strain influenza vaccine (Fluzone® Quadrivalent) in Canada. This new vaccine was introduced …

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States

Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season July 22, 2014 Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone® (Influenza Vaccine) for the 2014-2015 influenza (“the flu”) season have been released by the …

Influenza vaccines: Adenovirus-vectored influenza rapid-and-prolonged-immunologicals-therapeuticals

Influenza vaccines remain a significant area of research within the vaccines industry. Dr De-chu C. Tang, Founder, Vice President and Chief Technology Officer of Vaxin Inc joined us at the World Influenza Congress 2011 to discuss Vaxin's goal to develop an influenza rapid-and-prolonged-immunologicals-therapeuticals (RAPIT) that can be mass-produced at low costs and mass-administered by non-medical personnel; with the capability to …

Maintaining the link between seasonal influenza #vaccine production and pandemic readiness

Dr Tony Colegate, Influenza Technical Affairs Manager; Scientific Coordinator at IFPMA IVS, Novartis Vaccines & Diagnostics joined us in 2011 at the World Influenza Congress to share his views on the link between seasonal influenza vaccine production and pandemic readiness. His presentation included the following topics: About IFPMA and the IVS International Task Force What are the challenges of influenza …

Download: Discover the 6 key growth areas in the #vaccine industry

As the vaccine industry grows year on year, isn’t it essential you benchmark your strategies against the competition? With this in mind we organized this year’s World Vaccine Congress Lyon, focusing on precisely those top 6 key growth areas that will help you stay at the forefront of the industry. Expert speakers and industry strategists will come together in Lyon …